Study design
Institutional Review Board of the Medical University of South Carolina approved this phase 0 study. Written informed consent was obtained from parents prior to enrollment. An independent safety committee monitored adverse events. Inclusion criteria: Clinically stable infants, on minimal respiratory support (nasal cannula, or room air), who are either premature >33weeks gestational age (GA), or 35weeks with HIE, and working on oral feeding. Exclusion criteria: Infants who are unstable requiring respiratory support, or have major congenital anomalies or cardiomyopathy.
taVNS stimulation protocol
Participants received active taVNS via custom-made electrodes placed on the left tragus. Stimulation was delivered by a Digitimer DS7AH (Fig. 1) . We determined the Perceptual Threshold (PT) at rest prior to sessions 1 & 6 starting with 0.1mA, frequency 25Hz, pulse width 500ms. We increased stimulation in 0.1mA increments until the PT was achieved by observation of the infant's facial expression, fidgety movements, or Neonatal pain scale score (NIPS). We then decreased stimulation by 0.1mA below the PT and delivered taVNS while the infant was actively sucking from the bottle, to ensure coupling of motor activity and stimulation. We stopped stimulation when the infant stopped sucking, or at the end of a 2-minute train of successful sucking (due to concerns about skin damage from the stimulation). We conducted taVNSpaired feeding once a day, up to 30 minutes, for 10e22 days. Software recorded the actual amount and duration of stimulus during each session up to the maximum of 30-minute feeding session. Physiological data including heart rate (HR) was collected by routine cardiorespiratory monitoring. The NIPS score was recorded at start, middle and end of taVNS session.
Demographics
Four patients were born prematurely (25e27 weeks GA, 665e990 grams), and one was born at 35 weeks GA and suffered HIE. Infants were >42 weeks GA when enrolled (mean: 47.2 weeks GA; sd: 5.86; range: 42e53 weeks GA), and were candidates for Gtube placement. Full oral feeds were defined as 130 cc/kg/day, with adequate weight gain for discharge.
HR reduction with taVNS
taVNS produced a mean decrease of 20 ± 9 bpm or 13 ± 5% drop in HR within 20 ± 10 seconds after starting stimulation with feeding (as also seen in healthy adult volunteers [9] ). The effect of taVNS on heart rate was transient, within the normal limits of neonatal heart rate fluctuations, and not of clinically significant magnitude, but was reproducible in the 5 enrolled infants. The heart rate change with onset of stimulation was so reproducible that we adjusted positioning of the electrodes when the heart rate decrease was not observed, to ensure target attainment after burping or repositioning the infant. Our early experience in these neonates suggests that heart rate changes may be used to monitor 
Outcome
The infants had attempted p.o. feeds for 30e101 days prior to taVNS. Daily feeding volumes at enrollment were 35e64% of total feeds for the 7 days prior to treatment. Patients received 10e25 taVNS sessions. One infant received 25 treatments at parents' request. In these infants who had feeding difficulty due to delayed initiation of feeds from illness or prematurity, 4 of the 5 infants were able to achieve full oral feedings and weight gain adequate for discharge. These 4 attained full oral feeds within 7e23 days from the start of taVNS-paired feeding. Three infants avoided Gtubes. One attained full oral feedings for 4 days but received a Gtube during another surgery for hernia repair, per mother's request, to be used in case feeding deteriorated in the post-operative period.
Safety
We stimulated a mean of 14±6min during active sucking. Using subthreshold taVNS (mean 0.84 ± 0.17mA), there were no adverse events of bradycardia (HR < 80 bpm), worsening of swallowing, hoarseness, earlobe skin irritation or burns, or elevation of neonatal infant pain scale scores.
Conclusions
taVNS paired with feeding in newborns is feasible with promising preliminary results. Further refinements and formal doubleblind testing are needed to determine if our approach enhances learning and mastery of this important motor task. To speculate this early is not wise, however, preliminary data suggests that treatment efficacy may be based on the infant's baseline number of feeds by mouth and may not necessarily be related to postnatal age. If taVNS paired-feeding improves oromotor skills, it may also be useful in other forms of rehabilitation in newborns, infants, and children.
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